Cardinal Health names new CEO, chairman

Michael Bassett | | Health Imaging | Artificial Intelligence
Cardinal Health of Dublin, Ohio, has named George Barrett its new chairman and CEO.

Barrett joined Cardinal in January 2008 and has served as vice chairman and CEO of its healthcare supply chain services segment. He replaces R. Kerry Clark, who announced his retirement would be effective upon the completion of the spinoff of CareFusion.

Simultaneous to Barrett's appointment, the Cardinal board also authorized a $500 million share repurchase program, with the objective of offsetting dilution from equity grants associated with the company’s long-term employee incentive program.

Michael Bassett,

Contributor

Related Content

New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
New algorithm is twice as accurate at predicting stroke timing compared to the standard of care

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.